Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C29H32N2O6S.C4H4O4 |
Molecular Weight | 652.711 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)\C=C\C(O)=O.COC1=CC=C(OCCCN(C)CCOC2=CC=C3OCOC3=C2)C(=C1)[C@H]4SC5=CC=CC=C5N(C)C4=O
InChI
InChIKey=DIEJEELGDWGUCV-CNTJLTAHSA-N
InChI=1S/C29H32N2O6S.C4H4O4/c1-30(14-16-34-21-10-12-25-26(18-21)37-19-36-25)13-6-15-35-24-11-9-20(33-3)17-22(24)28-29(32)31(2)23-7-4-5-8-27(23)38-28;5-3(6)1-2-4(7)8/h4-5,7-12,17-18,28H,6,13-16,19H2,1-3H3;1-2H,(H,5,6)(H,7,8)/b;2-1+/t28-;/m1./s1
Molecular Formula | C29H32N2O6S |
Molecular Weight | 536.639 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Molecular Formula | C4H4O4 |
Molecular Weight | 116.0722 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 1 |
Optical Activity | NONE |
Semotiadil (also known as sesamodil or SD 3211) is a (+)-(R)-stereoisomer, the corresponding (−)-(S)-stereoisomer is called levosemotiadil. Semotiadil, a benzothiazine derivative was developed as a novel Ca2+ channel blocker with antiplatelet activity. Experiments on rodents have revealed that the drug had an advantage in the treatment of angina with regard to long-lasting action and selectivity for coronary artery and myocardium. In addition, semotiadil improved survival of rats with monocrotaline-induced pulmonary hypertension: comparison with diltiazem. Semotiadil was studied in phase II clinical trials for the treatment of angina pectoris and hypertension in Europe, and in Japan for the treatment of arrhythmias. However, the further development of semotiadil has now been discontinued.
Originator
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 18:07:35 GMT 2023
by
admin
on
Fri Dec 15 18:07:35 GMT 2023
|
Record UNII |
48E2Q389VX
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
116476-14-3
Created by
admin on Fri Dec 15 18:07:35 GMT 2023 , Edited by admin on Fri Dec 15 18:07:35 GMT 2023
|
PRIMARY | |||
|
6437846
Created by
admin on Fri Dec 15 18:07:35 GMT 2023 , Edited by admin on Fri Dec 15 18:07:35 GMT 2023
|
PRIMARY | |||
|
m9855
Created by
admin on Fri Dec 15 18:07:35 GMT 2023 , Edited by admin on Fri Dec 15 18:07:35 GMT 2023
|
PRIMARY | Merck Index | ||
|
48E2Q389VX
Created by
admin on Fri Dec 15 18:07:35 GMT 2023 , Edited by admin on Fri Dec 15 18:07:35 GMT 2023
|
PRIMARY | |||
|
DTXSID201034884
Created by
admin on Fri Dec 15 18:07:35 GMT 2023 , Edited by admin on Fri Dec 15 18:07:35 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
|
||
|
PARENT -> SALT/SOLVATE |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|